Pay in 4 interest-free payments of $61.50 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
658084-23-2
while binding to the low affinity site blocks the channel
InChiKey: NNACHAUCXXVJSP-UHFFFAOYSA-N
is an investigational drug candidate for metastatic colorectal cancer
4S)-4-amino-2-{[(1R)-1
Rilmenidine hemifumarate iKan 083 658084-23-2Rilmenidine hemifumarate, an innovative antihypertensive agent, is an orally active, selective I1 imidazoline receptor agonist. Rilmenidine hemifumarate is an alpha 2 adrenoceptor agonist. Rilmenidine hemifumarate induces autophagy. Rilmenidine hemifumarate acts both centrally by reducing sympathetic overactivity and in the kidney by inhibiting the Na+ H+ antiport. Rilmenidine hemifumarate modulates proliferation and stimulates the proapoptotic
US$ 14.00
US$ 36.00
US$ 11.00
US$ 20.00
US$ 167.00
US$ 95.00
US$ 85.00
US$ 129.00
US$ 44.00
US$ 170.00